Knocking out HNRNPU enhanced cisplatin sensitivity by regulating DNA damage repair genes, suggesting that targeting HNRNPU could offer a potential therapeutic approach for cisplatin-resistant bladder cancer. The gene discussed is HNRNPU; the disease is urinary bladder cancer.